Pricing Log in Create free account

Clene Inc. (CLNN) vs XBiotech Inc. (XBIT)

Clene Inc. and XBiotech Inc. are both Biotechnology companies. Clene Inc. and XBiotech Inc. are of similar size ($57.0M and $56.4M). Clene Inc. grew revenue faster over the last twelve months: 11.2% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −11,271.4%) and the lower return on invested capital (−159.2% vs 0.00%). Across the 16 metrics below, Clene Inc. leads on 9 and XBiotech Inc. on 7.

Valuation

Metric CLNN XBIT Biotechnology median
P/E n/m n/m 10.60
P/S 211.59 14.29 9.40
P/B n/m 0.45 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.90 0.66
EV/Sales 196.34 (10.46) 9.02
Earnings yield (61.06%) (78.72%) (32.88%)
Free cash flow yield (33.01%) (71.50%) (23.13%)

Profitability

Metric CLNN XBIT Biotechnology median
Gross margin 68.49% 0.00% 68.51%
Operating margin (8,928.57%) 0.00% 0.00%
Net margin (11,271.43%) 0.00% 0.00%
Free cash flow margin (6,984.45%) 0.00% 0.00%
Return on equity 197.50% (29.94%) (51.96%)
Return on assets (120.65%) (28.90%) (46.06%)
Return on invested capital 0.00% (159.18%) 0.00%

Growth

Metric CLNN XBIT Biotechnology median
Revenue growth (TTM) 11.21% (78.20%) 6.76%
EPS growth (last fiscal year) 53.26% (18.25%) 29.88%
Revenue growth, 5-year CAGR (0.59%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN XBIT Biotechnology median
Debt to equity (0.42) 0.00 0.00
Current ratio 0.85 33.15 4.97
Net debt to EBITDA (0.39) 2.33 1.01

Dividend

Metric CLNN XBIT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLNN XBIT Biotechnology median
Market cap 56.43m 57.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack